Risk factors for mortality in septic patients who received etomidate

The American Journal of Emergency Medicine
Megan A RechEthan Sterk

Abstract

To characterize risk factors for mortality in septic patients who received etomidate for rapid sequence intubation. This study was a retrospective cohort conducted at a large, tertiary, urban, academic medical center that included patients with severe sepsis or septic shock who received etomidate between January 1, 2010, and December 31, 2012. A total of 169 patients were included with similar baseline characteristics. There were more men in the nonsurvivor group than in the survivor group (67.1% vs 50.6%, P=.03). Septic shock occurred in 91.5% of nonsurvivors and 69% of survivors (P<.01). Nonsurvivors also had a higher initial lactate of (5.1±4.3 mmol/L vs 3.6±3.4 mmol/L, P=.02) and more vasopressor therapy (91.5% vs 69%, P<.01), required a higher number of vasopressors (2.2±1.1 vs 1.3±1, P<.01), and were administered hydrocortisone (53.7% vs 34.5%, P=.01). Abdominal source of sepsis (P=.048) and number of vasopressors (P=.01) were predictive of 30-day mortality. An alternative sedative induction agent may be considered for use in rapid sequence intubation in patients on multiple vasopressors or with abdominal source of infection.

References

Mar 4, 2000·JAMA : the Journal of the American Medical Association·D AnnaneE Bellissant
Dec 20, 2007·Intensive Care Medicine·Marc VinclairJean-François Payen
Feb 29, 2008·The New England Journal of Medicine·James A RussellUNKNOWN VASST Investigators
Dec 6, 2008·Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine·Karis L TekwaniErik B Kulstad
Dec 23, 2008·The Journal of Emergency Medicine·William K MallonRon M Walls
Aug 5, 2009·Intensive Care Medicine·Brian H CuthbertsonYoram G Weiss
Jul 24, 2010·Chest·Dayton DmelloGeorge M Matuschak
Mar 12, 2011·Internal and Emergency Medicine·Robert EhrmanMarie Mullen
Jun 27, 2012·Journal of Intensive Care Medicine·Curig O Prys-PicardGulshan Sharma
Aug 25, 2012·The Canadian Journal of Hospital Pharmacy·Mary ElliotI Fan Kuo
Jan 31, 2013·Intensive Care Medicine·R P DellingerUNKNOWN Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup
Mar 12, 2013·International Journal of Surgery·Elroy Patrick Weledji, Marcelin Ngowe Ngowe

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.